世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

India Pacemaker Market, By Product (External pacemakers, Implantable pacemakers), By Application (Bradycardia, Acute Myocardial Infarction, Arrhythmias, Congestive Heart Failure, Others), By End User (Hospitals, Outpatient Facilities), By Region, Competition, Forecast & Opportunities,  2020-2030F

India Pacemaker Market, By Product (External pacemakers, Implantable pacemakers), By Application (Bradycardia, Acute Myocardial Infarction, Arrhythmias, Congestive Heart Failure, Others), By End User (Hospitals, Outpatient Facilities), By Region, Competition, Forecast & Opportunities, 2020-2030F


Market Overview The India Pacemaker Market was valued at USD 220.75 million in 2024 and is projected to reach USD 299.07 million by 2030, growing at a CAGR of 5.15% during the forecast period. The... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年5月16日 US$3,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 85 英語

 

Summary

Market Overview
The India Pacemaker Market was valued at USD 220.75 million in 2024 and is projected to reach USD 299.07 million by 2030, growing at a CAGR of 5.15% during the forecast period. The market is expanding steadily, supported by the rising incidence of cardiovascular diseases, an aging population, increasing public awareness around cardiac care, and continuous innovation in pacemaker technologies. As demand rises for minimally invasive procedures and advanced cardiac rhythm solutions, India is witnessing a transition from conventional devices to modern options such as leadless pacemakers and AI-enabled systems. The development of healthcare infrastructure and improved accessibility to cardiac care in both public and private settings is also contributing to market expansion. While cost and rural healthcare access remain barriers, companies that focus on affordability, technology adaptation, and geographic outreach are poised to tap into the long-term growth potential of this evolving sector.
Key Market Drivers
Rising Prevalence of Cardiovascular Diseases (CVDs)
The increasing burden of cardiovascular diseases is a major catalyst for pacemaker market growth in India. With an estimated 11% overall prevalence of CVDs among adults—and a higher rate of 33.6% among those aged 60 and above—the country faces a substantial patient population in need of cardiac rhythm management. Many of these patients experience arrhythmias, including bradycardia, that require pacemaker implantation. Widespread risk factors such as hypertension, diabetes, sedentary lifestyles, and poor diet are accelerating disease onset, even among younger individuals. Urbanization is amplifying these trends, with lifestyle changes in cities contributing to early-stage cardiac complications. Arrhythmias are linked to over 90% of cardiac arrest cases, underscoring the critical role of pacemakers in life-saving interventions. As urban populations increase and awareness improves, the volume of pacemaker procedures is expected to rise in parallel with demand for more sophisticated cardiac devices.
Key Market Challenges
High Cost of Pacemaker Devices and Procedures
The cost barrier remains a major constraint in the widespread adoption of pacemakers in India. Advanced devices like dual-chamber or leadless pacemakers, coupled with associated hospital and surgical expenses, make implantation financially out of reach for many patients, especially in lower-income and rural populations. Health insurance coverage in these regions is often limited, and patients frequently defer or avoid treatment due to financial burden. As a result, despite clinical benefits, the adoption of next-generation technologies is slower, impacting overall procedural volumes. Manufacturers and healthcare providers must consider cost-reduction strategies through local production, value-based pricing, and accessible financing options to overcome this limitation and expand market access.
Key Market Trends
Shift Toward Leadless and Minimally Invasive Pacemaker Technologies
There is growing momentum in the adoption of leadless pacemakers in India, reflecting a broader trend toward minimally invasive and next-generation cardiac care solutions. Leadless devices eliminate the use of traditional leads, reducing complications like infections and lead displacement, and offering improved patient safety and quicker recovery. This technology appeals especially to younger and active patients seeking effective yet low-impact interventions. While currently concentrated in major urban hospitals, the demand for leadless pacemakers is expected to expand as affordability improves and clinician familiarity increases. Companies that focus on physician training, educational outreach, and localized marketing are likely to gain a competitive advantage as this technology becomes more mainstream.
Key Market Players
• Osypka Medical
• Boston Scientific Corporation
• ZOLL Medical India Pvt Ltd
• Asahi Kasei India Pvt. Ltd.
• India Medtronic Private Limited
• BIOTRONIK Medical Devices India Private Ltd.
• MicroPort Scientific Corporation
• Lepu Medical Technology (Beijing) Co., Ltd.
• Abbott
Report Scope:
In this report, the India Pacemaker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• India Pacemaker Market, By Product:
o External Pacemakers
o Implantable Pacemakers
• India Pacemaker Market, By Application:
o Bradycardia
o Acute Myocardial Infarction
o Arrhythmias
o Congestive Heart Failure
o Others
• India Pacemaker Market, By End User:
o Hospitals
o Outpatient Facilities
• India Pacemaker Market, By Region:
o North India
o East India
o West India
o South India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India Pacemaker Market.
Available Customizations:
India Pacemaker market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).


ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. India Pacemaker Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (External pacemakers, Implantable pacemakers)
5.2.2. By Application (Bradycardia, Acute Myocardial Infarction, Arrhythmias, Congestive Heart Failure, Others)
5.2.3. By End User (Hospitals, Outpatient Facilities)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North India Pacemaker Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
7. South India Pacemaker Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
8. East India Pacemaker Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
9. West India Pacemaker Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. India Pacemaker Market: SWOT Analysis
13. Competitive Landscape
13.1. Osypka Medical
13.1.1. Business Overview
13.1.2. Product & Service Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. Financials (If Listed)
13.1.6. SWOT Analysis
13.2. Boston Scientific Corporation
13.3. ZOLL Medical India Pvt Ltd
13.4. Asahi Kasei India Pvt. Ltd.
13.5. India Medtronic Private Limited
13.6. BIOTRONIK Medical Devices India Private Ltd.
13.7. MicroPort Scientific Corporation
13.8. Lepu Medical Technology (Beijing)Co.,Ltd.
13.9. Abbott
14. Strategic Recommendations
15. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社のヘルスケア分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/05/19 10:28

145.94 円

163.75 円

196.93 円

ページTOPに戻る